Theravance Biopharma, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
George Town, Grand Cayman, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Theravance Biopharma, Inc. has filed 1,125 SEC EDGAR filings since 01 Aug 2013

SEC filing history

Showing 901-925 of 1,000 matching filings.

Per page
25
Current page
37
4

FORM 4 -

Filing date
24 May 2016
Reporting date
20 May 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-88552

SC 13D/A filing

Filing date
13 May 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36033

THERAVANCE BIOPHARMA, INC. 8-K

Filing date
09 May 2016
Reporting date
09 May 2016
Next action
Verify source filing
8-K File 001-36033

8-K

Filing date
06 May 2016
Reporting date
03 May 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
05 May 2016
Reporting date
03 May 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
05 May 2016
Reporting date
03 May 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
05 May 2016
Reporting date
03 May 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
05 May 2016
Reporting date
03 May 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
05 May 2016
Reporting date
03 May 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
05 May 2016
Reporting date
03 May 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
05 May 2016
Reporting date
03 May 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
05 May 2016
Reporting date
03 May 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
05 May 2016
Reporting date
03 May 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
05 May 2016
Reporting date
03 May 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36033

THERAVANCE BIOPHARMA, INC. 8-K

Filing date
04 May 2016
Reporting date
04 May 2016
Next action
Verify source filing
424B5 File 333-205275

424B5

Filing date
29 Apr 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
FWP File 333-205275

FWP

Filing date
29 Apr 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-205275

424B5

Filing date
27 Apr 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-36033

DEF 14A

Filing date
25 Mar 2016
Reporting date
03 May 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-88552

SC 13D filing

Filing date
24 Mar 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
17 Mar 2016
Reporting date
15 Mar 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
17 Mar 2016
Reporting date
15 Mar 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
17 Mar 2016
Reporting date
15 Mar 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .